You could argue that anything done in a new way, however small, can be counted as an innovation. Introducing innovation at a game-changing level, however, is not so simple, and it's only going to get harder for the pharmaceutical industry.
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Director of Business Development
Latest News by Miles Wilson
Aethlon Medical to expand Hepatitis C treatments
In a press statement, Aethlon Medical Inc has announced it has entered into an agreement with GVK...
read moreComments
Is the H1N1 virus still a threat?
Last year, the world was told to prepare for a possible pandemic that had the potential to kill...
read moreComments
AstraZeneca to settle Seroquel US lawsuits
AstraZeneca, one of the UK’s largest pharmaceutical firms, has agreed to settle around 17,500 US...
read moreComments
Five Prime Therapeutics partners with Glaxo
Private drug developer Five Prime Therapeutics Inc has reportedly entered a partnership with...
read moreComments
Patent to be broken on Genzyme drug?
While Genzyme may be dealing with a take-over bid from Sanofi-Aventis, they are now facing...
read moreComments
Merck to team up with Sinopharm
Merck & Co. are team up with Chinese drug-maker Sinopharm, one of the country’s biggest...
read moreComments
Brilinta to be tested for approval
AstraZeneca’s anti-clotting drug, Brilinta, is set to be scrutinized by an expert panel, who will...
read moreComments
Glaxo profits fall by 92%
The UK’s largest drugmaker, GlaxoSmithKline, has seen its Q2 profits fall by a massive 92...
read moreComments
Jevtana approved by regulators
Sanofi-Aventis’ chemotherapy agent Jevtana has been approved by US regulators along with the...
read moreComments
Blood pressure drugs cancer risk
A host of blood pressure drugs, including Novartis drug Diovan, are being investigated by the FDA...
read moreComments
Next Generation Healthcare Summit
25th - 27th October 2010
As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.